We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Scores a Legal Win in the Ongoing 340B Discount Drug Program Saga
AstraZeneca Scores a Legal Win in the Ongoing 340B Discount Drug Program Saga
A federal judge has ruled that the government incorrectly threatened AstraZeneca with fines for limiting discounts to the controversial 340B Drug Discount program for safety-net hospitals.